Clinicopathologic Characteristics of Neuroendocrine Tumor of the Stomach.
- Author:
Yong Ho KIM
1
;
Sung Tae OH
;
Dong Hae JEONG
;
Jeong Hwan YOOK
;
Byung Sik KIM
;
Keon Chun PARK
Author Information
1. Department of Surgery Gastrointestinal division, University of Ulsan, College of Medicine and Asan Medical Center, Seoul, Korea.
- Publication Type:Original Article
- Keywords:
Gastric neuroendocrine tumor;
Hepatic metastasis;
CEA
- MeSH:
Chungcheongnam-do;
Diagnosis;
Drug Therapy;
Follow-Up Studies;
Humans;
Korea;
Liver;
Neoplasm Metastasis;
Neuroendocrine Tumors*;
Prognosis;
Recurrence;
Retrospective Studies;
Stomach Neoplasms;
Stomach*;
Ulcer
- From:Journal of the Korean Surgical Society
2000;58(5):650-655
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
PURPOSE: Very few cases of neuroendocrine tumor of the stomach have been reported in Korea. The prognosis of gastric neuroendocrine tumors is known to be poorer than that of ordinary gastric carcinomas. The purpose of this retrospective study was to review the clinicopathologic features of seven cases of this unusual gastric tumor. METHODS: Excluding the tumor containing only sparse neuroendocrine differentiation, we resected 7 typical neuroendocrine tumors from January 1995 to December 1997 at Asan Medical Center; 2,346 gastric cancer patients were treated surgically during the same period. Average follow up period was 22.6 months. RESULTS: A typical well demarcated tumor margin was observed in four of the seven cases. The entire tumor was located on the distal stomach. Even when the tumor had deep ulcerations, the tumor cells had not infiltrated the serosal layer. Three cases showed recurrence of disease. All the recurrences were found in the liver within 12 months, and two of them, who were not indicated for chemotherapy, died within 10 months after diagnosis of recurrence. One patient with a recurrence was treated with systemic chemotherapy just after the diagnosis and was still alive after 29 months. CONCLUSION: Gastric neuroendocrine tumor frequently recurs the liver even in an early stage and especially when preoperative CEA is increased. We experienced a case of successful control of hepatic metastasis by using systemic chemotherapy.
